PATENT CLAIM ANALYSIS

Application Number: 15754191
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "282000"]

Abstract:
The presently disclosed subject matter provides methods for inhibiting the growth and/or survival of bacteria from the  Borrelia  genus and for treating Lyme disease. These methods include agents that inhibit the glutathione/γ-glutamyl pathway and are involved in protection against free radical damage, cell membranes, energy production, and/or reactive oxygen species production. Many of these compounds are antimicrobial agents (antibiotics, antivirals, antifungals, anthelmintics or antiparasitics) and drugs used for treating other non-infectious conditions.

Claim (Index 17):
The method of  claim 1 , wherein the patient has, or is suspected of having, post-treatment Lyme disease syndrome (PTLDS) and/or antibiotic refractory Lyme arthritis.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.31746
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15799573', '15200657', '15539442', '15501469', '12676794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7117201122169946
- 35 USC 102 Novelty (BERT): 0.4848252137935753
- Combined Prediction Score: 0.6890306223746526
- Mean Citation Score: 165.459292
- Max Citation Score: 170.63629
- Similarity Product: 126.02232462454796

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test